Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00624416 · ClinicalTrials.gov registry record · Phase 1
Association of Beta-2 Adrenergic Agonist and Corticosteroid Injection in the Treatment of Lipomas
A Phase 1 study, sponsored by Pennington Biomedical Research Center.
- Completed
- Registry status
- Phase 1
- Development phase
- 10
- Enrollment target
NCT00624416: Completed Phase 1 study, sponsored by Pennington Biomedical Research Center.
NCT00624416 is a Phase 1 study that has completed, run by Pennington Biomedical Research Center. The registered enrollment target is 10 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (83% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00624416, a Phase 1 study, has completed, sponsored by Pennington Biomedical Research Center.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 10 participants
- Enrollment target
Study Summary
The purpose of this study is to test whether injected medications will increase the amount of fat released by a fat cell. We will compare prednisolone (a synthetic cortisone) combined with isoproterenol (a drug given for asthma) versus using isoproterenol alone. We will also test if injections of isoproterenol and prednisolone will shrink the size of lipomas, which are benign fatty tumors.
Interventions
- DRUG Prednisolone synthetic cortisone and Isoproterenol together
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2007-10 |
| Est. Completion | 2009-03 |
| Phase | Phase 1 |
What the finished NCT00624416 record still lists
NCT00624416 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (83% lower).
The record links to 0 conditions, and to 1 intervention - of which Prednisolone synthetic cortisone and Isoproterenol together is the first listed.
NCT00624416 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00624416 about?
NCT00624416 is a clinical study titled "Association of Beta-2 Adrenergic Agonist and Corticosteroid Injection in the Treatment of Lipomas". The purpose of this study is to test whether injected medications will increase the amount of fat released by a fat cell. We will compare prednisolone (a synthetic cortisone) combined with isoproterenol (a drug given for asthma) versus using isoproterenol alone. We will also test if injections of is...
What is the current status of trial NCT00624416?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 10 participants. The study started on 2007-10. Estimated completion is 2009-03.
What interventions are being tested in trial NCT00624416?
The interventions under investigation include: Prednisolone synthetic cortisone and Isoproterenol together (DRUG).
Who is sponsoring clinical trial NCT00624416?
This trial is sponsored by Pennington Biomedical Research Center, which has 258 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00624416's enrollment target sits among peer trials
10 1913th of 2000 higher than 46 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia